These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26086472)

  • 1. Efavirenz Has the Highest Anti-Proliferative Effect of Non-Nucleoside Reverse Transcriptase Inhibitors against Pancreatic Cancer Cells.
    Hecht M; Erber S; Harrer T; Klinker H; Roth T; Parsch H; Fiebig N; Fietkau R; Distel LV
    PLoS One; 2015; 10(6):e0130277. PubMed ID: 26086472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability.
    Usach I; Melis V; Peris JE
    J Int AIDS Soc; 2013 Sep; 16(1):1-14. PubMed ID: 24008177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of Efavirenz in BxPC-3 pancreatic cancer cells is based on oxidative stress and is synergistic with ionizing radiation.
    Hecht M; Harrer T; Körber V; Sarpong EO; Moser F; Fiebig N; Schwegler M; Stürzl M; Fietkau R; Distel LV
    Oncol Lett; 2018 Feb; 15(2):1728-1736. PubMed ID: 29434868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.
    Lugini L; Sciamanna I; Federici C; Iessi E; Spugnini EP; Fais S
    Oncotarget; 2017 Jan; 8(3):4147-4155. PubMed ID: 27926505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecules of Natural Origin as Potential Anti-HIV Agents: A Computational Approach.
    Crisan L; Bora A
    Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of HIV Prevention of Mother-To-Child Transmission Programs in Sub-Saharan Africa: Longitudinal Assessment of 64 Nevirapine-Based Programs Implemented in 25 Countries, 2000-2011.
    Ladner J; Besson MH; Rodrigues M; Saba J; Audureau E
    PLoS One; 2015; 10(6):e0130103. PubMed ID: 26098311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.
    Pereira M; Vale N
    Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model.
    Zizioli D; Ferretti S; Tiecco G; Mignani L; Monti E; Castelli F; Quiros-Roldan E; Zanella I
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition.
    Islam S; Rahaman MH; Yu M; Noll B; Martin JH; Wang S; Head R
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology.
    Pereira M; Vale N
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.
    Nishikawa S; Iwakuma T
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efavirenz: History, Development and Future.
    Costa B; Vale N
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of metformin/efavirenz/fluoxetine exhibits profound anticancer activity via a cancer cell-specific ROS amplification.
    Kang BG; Shende M; Inci G; Park SH; Jung JS; Kim SB; Kim JH; Mo YW; Seo JH; Feng JH; Kim SC; Lim SS; Suh HW; Lee JY
    Cancer Biol Ther; 2023 Dec; 24(1):20-32. PubMed ID: 36588385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Epigenetic
    Lavia P; Sciamanna I; Spadafora C
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined
    Islam S; Teo T; Kumarasiri M; Slater M; Martin JH; Wang S; Head R
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Antiretroviral Drugs Zidovudine and Efavirenz Impairs Tumor Growths in a Mouse Model of Cancer.
    Schneider MA; Buzdin AA; Weber A; Clavien PA; Borger P
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel-induced stress granules increase
    Shi X; Si X; Zhang E; Zang R; Yang N; Cheng H; Zhang Z; Pan B; Sun Y
    J Biomed Res; 2021 Oct; 35(6):411-424. PubMed ID: 34857678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
    De Lellis L; Veschi S; Tinari N; Mokini Z; Carradori S; Brocco D; Florio R; Grassadonia A; Cama A
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The profiling, identification, quantification and analysis of differentially expressed genes (DEGs) in response to drug treatment in lung cancer.
    Marima R; Hull R; Dlamini Z; Penny C
    MethodsX; 2021; 8():101381. PubMed ID: 34430277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Pfab C; Schnobrich L; Eldnasoury S; Gessner A; El-Najjar N
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.